Study of sss40 for cancer bone pain
Part of Pain clinical trials.
This trial tests a new injection called sss40 to treat moderate-to-severe pain caused by cancer that has spread to the bones. The goal is to see if it is safe and effective for people whose pain is not being controlled by current treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have cancer that has spread to your bones (bone metastases) confirmed by a scan.
- You have pain at a bone metastasis site that scores at least 4 out of 10 on average over 3 days.
- You weigh at least 40 kg (about 88 pounds).
- Your life expectancy is at least 3 months.
- You are willing to avoid certain chemotherapy drugs and other treatments during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new pain medication called 3D1002, when combined with a long-acting opioid, can better manage moderate to severe cancer pain compared to the opioid alone. The goal is to find a more effective way to reduce pain without increasing side effects.
This study tests an inhaled fentanyl spray for pain relief in Chinese adults with solid tumors. You may join if you have stable blood counts and organ function, and have not used strong painkillers recently.
This trial tests whether VC004 capsules can safely reduce pain caused by cancer that has spread to the bones. It may help patients who have bone pain and are looking for additional pain relief.
This trial compares two types of radiation therapy—standard palliative radiation and a more targeted high-dose treatment (SBRT)—to see which better relieves pain from bone metastases that have spread outside the spine. It is for people with solid tumors who have a painful bone spot and are expected to live at least 6 months.
This trial compares two types of radiation therapy to relieve pain from cancer that has spread to the bones. It aims to see whether a more targeted, high-dose approach (SBRT) works better than standard palliative radiation.
This trial tests a new drug, SSS59, in people with advanced solid tumors that have not responded to other treatments. It aims to see if the drug is safe and how it affects the body.
Hear when a new Cancer Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.